Transgenic mice that overexpress IGF-1 in the epidermis via either a K1 or K5 promoter are hypersensitive to the proliferative effects of TPA and develop skin tumors without carcinogen initiation [126,127]. This evidence concerns the gene KRT5 and skin neoplasm.